封面
市场调查报告书
商品编码
1457968

自我血糖测量设备的全球市场:市场规模和占有率分析(依类型、应用和最终用户)、工业需求预测(截至 2030 年)

Self-Monitoring Blood Glucose Devices Market Size and Share Analysis by Type, Application, End User - Global Industry Demand Forecast to 2030

出版日期: | 出版商: Prescient & Strategic Intelligence | 英文 270 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2023 年全球自我监测血糖 (SMBG) 设备市场规模将达到 253 亿美元。 预计2024年至2030年复合年增长率为9.7%,最终在2030年达到482亿美元。

该行业的发展受到糖尿病增加、老年人口增加、技术进步、糖尿病治疗意识增强以及肥胖人口增加等因素的推动。 此外,英国、美国、义大利、德国、法国、日本、西班牙等国家的SMBG设备报销指南也是推动产业发展的另一个重要原因。

测试条仍是销售量最大的设备类型

依类型划分,试纸的销售占有率最高,2023 年将达 40%。 此类试纸由一次性塑胶製成,充满葡萄糖氧化物,有助于检查血糖水平。 这些有利的葡萄糖测试条也可用于检查血液中的酮含量。

由于老年人和肥胖人口的增加,糖尿病发生率增加

世界老年人口正快速成长。

预计 65 岁及以上老年人口比例将从 2022 年的 10% 迅速增加到 2050 年的 16%,凸显了人口结构的重大变化。

这种老化趋势将成为SMBG装备产业发展的巨大动力。

北美引领市场

2023年,北美地区占比最大,达55%。

这一比例极高的原因是高血糖发病率不断上升、老年人口不断增加,以及高血糖在北美已成为一种与生活方式相关的重要疾病。

技术进步和创新产品的定期推出也有助于非洲大陆产业的发展。

本报告分析了全球自我血糖监测(SMBG)设备市场,并提供了有关市场的基本结构和最新情况、主要促进和抑制因素以及全球、依地区和主要市场规模趋势的资讯。前景(基于数量/价值,2017-2030 年)、依类型、应用和最终用户划分的详细趋势、市场竞争的现状以及主要公司的概况。

目录

第一章研究范围

第二章研究方法

第 3 章执行摘要

第 4 章市场指标

第五章产业展望

  • 市场动态
    • 趋势
    • 促进因素
    • 抑制因素/课题
    • 促进/抑制因子影响分析
  • 新型冠状病毒感染 (COVID-19) 的影响
  • 波特五力分析

第六章世界市场

  • 摘要
  • 市场规模:依类型划分(2017-2030 年)
  • 市场收入:依类型划分(2017-2030 年)
  • 市场规模:依应用划分(2017-2030 年)
  • 市场收入:依应用分类(2017-2030 年)
  • 市场规模:依最终用户划分(2017-2030 年)
  • 市场收入:以最终用户划分(2017-2030 年)
  • 市场规模:依地区划分(2017-2030 年)
  • 市场收入:依地区划分(2017-2030 年)

第七章北美市场

  • 摘要
  • 市场规模:依类型划分(2017-2030 年)
  • 市场收入:依类型划分(2017-2030 年)
  • 市场规模:依应用划分(2017-2030 年)
  • 市场收入:依应用分类(2017-2030 年)
  • 市场规模:依最终用户划分(2017-2030 年)
  • 市场收入:以最终用户划分(2017-2030 年)
  • 市场规模:依国家划分(2017-2030 年)
  • 市场收入:依国家/地区划分(2017-2030 年)

第8章欧洲市场

第9章亚太市场

第10章拉丁美洲市场

第 11 章中东与非洲 (MEA) 市场

第12章美国市场

  • 摘要
  • 市场规模:依类型划分(2017-2030 年)
  • 市场收入:依类型划分(2017-2030 年)
  • 市场规模:依应用划分(2017-2030 年)
  • 市场收入:依应用分类(2017-2030 年)
  • 市场规模:依最终用户划分(2017-2030 年)
  • 市场收入:以最终用户划分(2017-2030 年)

第十三章加拿大市场

第14章德国市场

第十五章法国市场

第十六章英国市场

第十七章义大利市场

第十八章西班牙市场

第十九章日本市场

第20章中国市场

第21章印度市场

第22章澳洲市场

第23章韩国市场

第24章巴西市场

第25章墨西哥市场

第26章沙乌地阿拉伯市场

第27章南非市场

第 28 章阿联酋 (UAE) 市场

第29章竞争态势

  • 市场参与者及其提供的产品/服务的列表
  • 主要公司的竞争基准
  • 各大公司的产品基准
  • 近期策略发展状况

第30章公司简介

  • Johnson & Johnson Services Inc.
  • ARKRAY Inc.
  • Nova Biomedical
  • Bionime Corporation
  • Medtronic plc
  • B. Braun Melsungen AG
  • Abbott Laboratories
  • Bayer AG

第31章附录

简介目录
Product Code: 10484

In 2023, the worldwide self-monitoring blood glucose devices market accrued revenue of

USD 25.3 billion. It is anticipated to grow at a compound annual growth rate (CAGR) of 9.7% between 2024 and 2030, ultimately reaching USD 48.2 billion by 2030.

This development of the industry is credited to the growing occurrence of diabetes, the rising populace of elderly people, technical improvements, thriving awareness of diabetes care, increasing count of obese populations, and the compensation guidelines for SMBG devices in several nations, such as the U.K., the U.S., Italy, Germany, France, Japan, and Spain, are another significant reason propelling the industry development.

Market Trends

Technical Improvements in SMBG Devices: The worldwide SMBG industry is experiencing a trend of constant technical improvements in SMBG devices. Such innovations comprise the development of new-age instruments that significantly decrease the time taken to test sugar levels compared to traditional lab approaches.

Portability and Convenience: A major trend in the self-monitoring blood glucose devices market is the focus on portability and suitability. Several SMBG devices are made to be compact and simple to carry, offering users better flexibility and convenience in monitoring their blood glucose levels.

Smartphone Integration and Mobile Apps: Another notable trend is the integration of SMBG devices with smartphones and the widespread use of mobile apps. Smartphone apps are playing a crucial role in helping patients manage hyperglycemia by providing education on the condition, promoting healthy lifestyle choices, offering tools for tracking sugar levels, and facilitating medication adherence.

Mobile Sugar Checkers: Companies are increasingly introducing mobile sugar checkers that can be connected to smartphones. These devices allow users to monitor their sugar levels on the go and conveniently access their data through mobile apps, contributing to better management of diabetes and hyperglycemia.

Test Strips Remain the Top-Selling Device Type

In 2023, on the basis of type, the sale of strips had the largest share of 40%. Such strips are manufactured from disposable plastic and saturated with glucose oxides, which aid in checking the sugar level. These lucrative glucose measuring strips can also be utilized for checking the ketone level in the blood.

Increasing Diabetes Frequency with Thriving Elderly and Obese Populations

The worldwide elderly populace is witnessing quick development, as shown by the world population prospects report from the UN.

The share of people elderly 65 years or older is estimated to surge from 10% in 2022 to 16% by 2050, highlighting a substantial demographic shift.

This elderly trend is a major propeller for the development of the self-measuring blood glucose devices industry.

Elderly people are more vulnerable to diabetes in comparison to younger demographics, leading to an augmented need for blood glucose tracking devices between this age group.

North Americans Lead in Diabetes Self-Monitoring and Management

In 2023, the North American region held the largest share, 55%, of the industry.

This dominating regional position can be credited to the increasing occurrence of hyperglycemia and a rising elderly populace, making hyperglycemia a substantial lifestyle disease in North America.

Technical improvements and regular launches of innovative items are contributing to industry development in the continent.

Competition Analysis

For example, in 2022, Dexcom Inc. got FDA clearance for Dexcom G7 for all kinds of hyperglycemic patients ages two years and more in the U.S.

Table of Contents

Chapter 1. Research Scope

  • 1.1. Research Objectives
  • 1.2. Market Definition
  • 1.3. Analysis Period
  • 1.4. Market Size Breakdown by Segments
    • 1.4.1. Market size breakdown, by type
    • 1.4.2. Market size breakdown, by application
    • 1.4.3. Market size breakdown, by end user
    • 1.4.4. Market size breakdown, by region
    • 1.4.5. Market size breakdown, by country
  • 1.5. Market Data Reporting Unit
    • 1.5.1. Volume
    • 1.5.2. Value
  • 1.6. Key Stakeholders

Chapter 2. Research Methodology

  • 2.1. Secondary Research
    • 2.1.1. Paid
    • 2.1.2. Unpaid
    • 2.1.3. P&S Intelligence database
  • 2.2. Primary Research
  • 2.3. Market Size Estimation
  • 2.4. Data Triangulation
  • 2.5. Currency Conversion Rates
  • 2.6. Assumptions for the Study
  • 2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Market Indicators

Chapter 5. Industry Outlook

  • 5.1. Market Dynamics
    • 5.1.1. Trends
    • 5.1.2. Drivers
    • 5.1.3. Restraints/challenges
    • 5.1.4. Impact analysis of drivers/restraints
  • 5.2. Impact of COVID-19
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Bargaining power of buyers
    • 5.3.2. Bargaining power of suppliers
    • 5.3.3. Threat of new entrants
    • 5.3.4. Intensity of rivalry
    • 5.3.5. Threat of substitutes

Chapter 6. Global Market

  • 6.1. Overview
  • 6.2. Market Volume, by Type (2017-2030)
  • 6.3. Market Revenue, by Type (2017-2030)
  • 6.4. Market Volume, by Application (2017-2030)
  • 6.5. Market Revenue, by Application (2017-2030)
  • 6.6. Market Volume, by End User (2017-2030)
  • 6.7. Market Revenue, by End User (2017-2030)
  • 6.8. Market Volume, by Region (2017-2030)
  • 6.9. Market Revenue, by Region (2017-2030)

Chapter 7. North America Market

  • 7.1. Overview
  • 7.2. Market Volume, by Type (2017-2030)
  • 7.3. Market Revenue, by Type (2017-2030)
  • 7.4. Market Volume, by Application (2017-2030)
  • 7.5. Market Revenue, by Application (2017-2030)
  • 7.6. Market Volume, by End User (2017-2030)
  • 7.7. Market Revenue, by End User (2017-2030)
  • 7.8. Market Volume, by Country (2017-2030)
  • 7.9. Market Revenue, by Country (2017-2030)

Chapter 8. Europe Market

  • 8.1. Overview
  • 8.2. Market Volume, by Type (2017-2030)
  • 8.3. Market Revenue, by Type (2017-2030)
  • 8.4. Market Volume, by Application (2017-2030)
  • 8.5. Market Revenue, by Application (2017-2030)
  • 8.6. Market Volume, by End User (2017-2030)
  • 8.7. Market Revenue, by End User (2017-2030)
  • 8.8. Market Volume, by Country (2017-2030)
  • 8.9. Market Revenue, by Country (2017-2030)

Chapter 9. APAC Market

  • 9.1. Overview
  • 9.2. Market Volume, by Type (2017-2030)
  • 9.3. Market Revenue, by Type (2017-2030)
  • 9.4. Market Volume, by Application (2017-2030)
  • 9.5. Market Revenue, by Application (2017-2030)
  • 9.6. Market Volume, by End User (2017-2030)
  • 9.7. Market Revenue, by End User (2017-2030)
  • 9.8. Market Volume, by Country (2017-2030)
  • 9.9. Market Revenue, by Country (2017-2030)

Chapter 10. LATAM Market

  • 10.1. Overview
  • 10.2. Market Volume, by Type (2017-2030)
  • 10.3. Market Revenue, by Type (2017-2030)
  • 10.4. Market Volume, by Application (2017-2030)
  • 10.5. Market Revenue, by Application (2017-2030)
  • 10.6. Market Volume, by End User (2017-2030)
  • 10.7. Market Revenue, by End User (2017-2030)
  • 10.8. Market Volume, by Country (2017-2030)
  • 10.9. Market Revenue, by Country (2017-2030)

Chapter 11. MEA Market

  • 11.1. Overview
  • 11.2. Market Volume, by Type (2017-2030)
  • 11.3. Market Revenue, by Type (2017-2030)
  • 11.4. Market Volume, by Application (2017-2030)
  • 11.5. Market Revenue, by Application (2017-2030)
  • 11.6. Market Volume, by End User (2017-2030)
  • 11.7. Market Revenue, by End User (2017-2030)
  • 11.8. Market Volume, by Country (2017-2030)
  • 11.9. Market Revenue, by Country (2017-2030)

Chapter 12. U.S. Market

  • 12.1. Overview
  • 12.2. Market Volume, by Type (2017-2030)
  • 12.3. Market Revenue, by Type (2017-2030)
  • 12.4. Market Volume, by Application (2017-2030)
  • 12.5. Market Revenue, by Application (2017-2030)
  • 12.6. Market Volume, by End User (2017-2030)
  • 12.7. Market Revenue, by End User (2017-2030)

Chapter 13. Canada Market

  • 13.1. Overview
  • 13.2. Market Volume, by Type (2017-2030)
  • 13.3. Market Revenue, by Type (2017-2030)
  • 13.4. Market Volume, by Application (2017-2030)
  • 13.5. Market Revenue, by Application (2017-2030)
  • 13.6. Market Volume, by End User (2017-2030)
  • 13.7. Market Revenue, by End User (2017-2030)

Chapter 14. Germany Market

  • 14.1. Overview
  • 14.2. Market Volume, by Type (2017-2030)
  • 14.3. Market Revenue, by Type (2017-2030)
  • 14.4. Market Volume, by Application (2017-2030)
  • 14.5. Market Revenue, by Application (2017-2030)
  • 14.6. Market Volume, by End User (2017-2030)
  • 14.7. Market Revenue, by End User (2017-2030)

Chapter 15. France Market

  • 15.1. Overview
  • 15.2. Market Volume, by Type (2017-2030)
  • 15.3. Market Revenue, by Type (2017-2030)
  • 15.4. Market Volume, by Application (2017-2030)
  • 15.5. Market Revenue, by Application (2017-2030)
  • 15.6. Market Volume, by End User (2017-2030)
  • 15.7. Market Revenue, by End User (2017-2030)

Chapter 16. U.K. Market

  • 16.1. Overview
  • 16.2. Market Volume, by Type (2017-2030)
  • 16.3. Market Revenue, by Type (2017-2030)
  • 16.4. Market Volume, by Application (2017-2030)
  • 16.5. Market Revenue, by Application (2017-2030)
  • 16.6. Market Volume, by End User (2017-2030)
  • 16.7. Market Revenue, by End User (2017-2030)

Chapter 17. Italy Market

  • 17.1. Overview
  • 17.2. Market Volume, by Type (2017-2030)
  • 17.3. Market Revenue, by Type (2017-2030)
  • 17.4. Market Volume, by Application (2017-2030)
  • 17.5. Market Revenue, by Application (2017-2030)
  • 17.6. Market Volume, by End User (2017-2030)
  • 17.7. Market Revenue, by End User (2017-2030)

Chapter 18. Spain Market

  • 18.1. Overview
  • 18.2. Market Volume, by Type (2017-2030)
  • 18.3. Market Revenue, by Type (2017-2030)
  • 18.4. Market Volume, by Application (2017-2030)
  • 18.5. Market Revenue, by Application (2017-2030)
  • 18.6. Market Volume, by End User (2017-2030)
  • 18.7. Market Revenue, by End User (2017-2030)

Chapter 19. Japan Market

  • 19.1. Overview
  • 19.2. Market Volume, by Type (2017-2030)
  • 19.3. Market Revenue, by Type (2017-2030)
  • 19.4. Market Volume, by Application (2017-2030)
  • 19.5. Market Revenue, by Application (2017-2030)
  • 19.6. Market Volume, by End User (2017-2030)
  • 19.7. Market Revenue, by End User (2017-2030)

Chapter 20. China Market

  • 20.1. Overview
  • 20.2. Market Volume, by Type (2017-2030)
  • 20.3. Market Revenue, by Type (2017-2030)
  • 20.4. Market Volume, by Application (2017-2030)
  • 20.5. Market Revenue, by Application (2017-2030)
  • 20.6. Market Volume, by End User (2017-2030)
  • 20.7. Market Revenue, by End User (2017-2030)

Chapter 21. India Market

  • 21.1. Overview
  • 21.2. Market Volume, by Type (2017-2030)
  • 21.3. Market Revenue, by Type (2017-2030)
  • 21.4. Market Volume, by Application (2017-2030)
  • 21.5. Market Revenue, by Application (2017-2030)
  • 21.6. Market Volume, by End User (2017-2030)
  • 21.7. Market Revenue, by End User (2017-2030)

Chapter 22. Australia Market

  • 22.1. Overview
  • 22.2. Market Volume, by Type (2017-2030)
  • 22.3. Market Revenue, by Type (2017-2030)
  • 22.4. Market Volume, by Application (2017-2030)
  • 22.5. Market Revenue, by Application (2017-2030)
  • 22.6. Market Volume, by End User (2017-2030)
  • 22.7. Market Revenue, by End User (2017-2030)

Chapter 23. South Korea Market

  • 23.1. Overview
  • 23.2. Market Volume, by Type (2017-2030)
  • 23.3. Market Revenue, by Type (2017-2030)
  • 23.4. Market Volume, by Application (2017-2030)
  • 23.5. Market Revenue, by Application (2017-2030)
  • 23.6. Market Volume, by End User (2017-2030)
  • 23.7. Market Revenue, by End User (2017-2030)

Chapter 24. Brazil Market

  • 24.1. Overview
  • 24.2. Market Volume, by Type (2017-2030)
  • 24.3. Market Revenue, by Type (2017-2030)
  • 24.4. Market Volume, by Application (2017-2030)
  • 24.5. Market Revenue, by Application (2017-2030)
  • 24.6. Market Volume, by End User (2017-2030)
  • 24.7. Market Revenue, by End User (2017-2030)

Chapter 25. Mexico Market

  • 25.1. Overview
  • 25.2. Market Volume, by Type (2017-2030)
  • 25.3. Market Revenue, by Type (2017-2030)
  • 25.4. Market Volume, by Application (2017-2030)
  • 25.5. Market Revenue, by Application (2017-2030)
  • 25.6. Market Volume, by End User (2017-2030)
  • 25.7. Market Revenue, by End User (2017-2030)

Chapter 26. Saudi Arabia Market

  • 26.1. Overview
  • 26.2. Market Volume, by Type (2017-2030)
  • 26.3. Market Revenue, by Type (2017-2030)
  • 26.4. Market Volume, by Application (2017-2030)
  • 26.5. Market Revenue, by Application (2017-2030)
  • 26.6. Market Volume, by End User (2017-2030)
  • 26.7. Market Revenue, by End User (2017-2030)

Chapter 27. South Africa Market

  • 27.1. Overview
  • 27.2. Market Volume, by Type (2017-2030)
  • 27.3. Market Revenue, by Type (2017-2030)
  • 27.4. Market Volume, by Application (2017-2030)
  • 27.5. Market Revenue, by Application (2017-2030)
  • 27.6. Market Volume, by End User (2017-2030)
  • 27.7. Market Revenue, by End User (2017-2030)

Chapter 28. U.A.E. Market

  • 28.1. Overview
  • 28.2. Market Volume, by Type (2017-2030)
  • 28.3. Market Revenue, by Type (2017-2030)
  • 28.4. Market Volume, by Application (2017-2030)
  • 28.5. Market Revenue, by Application (2017-2030)
  • 28.6. Market Volume, by End User (2017-2030)
  • 28.7. Market Revenue, by End User (2017-2030)

Chapter 29. Competitive Landscape

  • 29.1. List of Market Players and their Offerings
  • 29.2. Competitive Benchmarking of Key Players
  • 29.3. Product Benchmarking of Key Players
  • 29.4. Recent Strategic Developments

Chapter 30. Company Profiles

  • 30.1. Johnson & Johnson Services Inc.
    • 30.1.1. Business overview
    • 30.1.2. Product and service offerings
    • 30.1.3. Key financial summary
  • 30.2. ARKRAY Inc.
    • 30.2.1. Business overview
    • 30.2.2. Product and service offerings
    • 30.2.3. Key financial summary
  • 30.3. Nova Biomedical
    • 30.3.1. Business overview
    • 30.3.2. Product and service offerings
    • 30.3.3. Key financial summary
  • 30.4. Bionime Corporation
    • 30.4.1. Business overview
    • 30.4.2. Product and service offerings
    • 30.4.3. Key financial summary
  • 30.5. Medtronic plc
    • 30.5.1. Business overview
    • 30.5.2. Product and service offerings
    • 30.5.3. Key financial summary
  • 30.6. B. Braun Melsungen AG
    • 30.6.1. Business overview
    • 30.6.2. Product and service offerings
    • 30.6.3. Key financial summary
  • 30.7. Abbott Laboratories
    • 30.7.1. Business overview
    • 30.7.2. Product and service offerings
    • 30.7.3. Key financial summary
  • 30.8. Bayer AG
    • 30.8.1. Business overview
    • 30.8.2. Product and service offerings
    • 30.8.3. Key financial summary

Chapter 31. Appendix

  • 31.1. Abbreviations
  • 31.2. Sources and References
  • 31.3. Related Reports